Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.25.0.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Schedule of Potentially Dilutive Securities Excluded from Computation of Diluted Shares

The following potentially dilutive securities have been excluded from the computation of diluted shares of common stock outstanding as they would be anti-dilutive:

 

    2024     2023  
    December 31,  
    2024     2023  
Common stock warrants August 2021     14,031       14,031  
Underwriter warrants August 2021     284       284  
Chanticleer warrants     6       6  
Series C warrants     2,297       2,297  
Series 3 warrants     1,566       1,566  
Unvested restricted stock units and awards     17,152       976  
Common stock warrants February 2023     31,563       33,982  
Underwriter warrants February 2023     1,933       1,933  
Common stock private placement warrants June 2023     28,409       28,409  
Placement agent warrants June 2023     852       852  
Common stock warrants October 2023     354,994       710,931  
Underwriter warrants October 2023     10,664       10,664  
Placement agent warrants June 2024     14,142        
Common stock warrants June 2024     703,125        
Common stock warrants November 2024     2,222,222        
Common stock registered direct warrants December 2024     1,085,325        
Common stock PIPE warrants December 2024     673,000        
Total anti-dilutive weighted average shares      5,161,565       805,931